https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-09-01 / Int J Hyperthermia 2003 Sep-Oct;19(5):520-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-09-01 / Int J Hyperthermia 2003 Sep-Oct;19(5):520-332003-09-01 00:00:002019-02-15 08:48:25Thermal regulation of dendritic cell activation and migration from skin explants
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-09-01 / Int. Immunol. 2003 Sep;15(9):1053-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-09-01 / Int. Immunol. 2003 Sep;15(9):1053-612003-09-01 00:00:002019-02-15 09:17:51Fever-like temperature induces maturation of dendritic cells through induction of hsp90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-08-01 / J Dtsch Dermatol Ges 2003 Aug;1(8):635-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-08-01 / J Dtsch Dermatol Ges 2003 Aug;1(8):635-422003-08-01 00:00:002003-08-01 00:00:00Efficacy of superficial and deep regional hyperthermia combined with systemic chemotherapy and radiotherapy in metastatic melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-06-01 / Eur. J. Immunol. 2003 Jun;33(6):1754-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-06-01 / Eur. J. Immunol. 2003 Jun;33(6):1754-622003-06-01 00:00:002019-02-15 09:17:52Heat shock factor 1-independent activation of dendritic cells by heat shock: implication for the uncoupling of heat-mediated immunoregulation from the heat shock response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-05-13 / World J Surg 2003 Jun;27(6):640-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-05-13 / World J Surg 2003 Jun;27(6):640-62003-05-13 00:00:002019-02-15 08:39:24Doxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-03-01 / Lung Cancer 2003 Mar;39(3):339-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-03-01 / Lung Cancer 2003 Mar;39(3):339-452003-03-01 00:00:002003-03-01 00:00:00Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-03-01 / Int J Hyperthermia 2003 Mar-Apr;19(2):103-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-03-01 / Int J Hyperthermia 2003 Mar-Apr;19(2):103-182003-03-01 00:00:002003-03-01 00:00:00The effect of whole-body hyperthermia combined with ‚metronomic‘ chemotherapy on rat mammary adenocarcinoma metastases
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Oncology 2003;65 Suppl 2:76-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Oncology 2003;65 Suppl 2:76-92003-01-01 00:00:002003-01-01 00:00:00Ifosfamide with regional hyperthermia in soft-tissue sarcomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Oncology 2003;64(4):312-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Oncology 2003;64(4):312-212003-01-01 00:00:002003-01-01 00:00:00A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-11-01 / Int J Hyperthermia 2002 Nov-Dec;18(6):506-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-11-01 / Int J Hyperthermia 2002 Nov-Dec;18(6):506-202002-11-01 00:00:002019-02-15 08:48:26Cancer immunotherapy: stress proteins and hyperthermia
